Integrated evaluation of PAM50 subtypes and immune...

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

Dieci, M. V., Prat, A., Tagliafico, E., Paré, L., Ficarra, G., Bisagni, G., Piacentini, F., Generali, D. G., Conte, P., Guarneri, V.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw262
Date:
August, 2016
File:
PDF, 218 KB
english, 2016
Conversion to is in progress
Conversion to is failed